Shares of Allergan were down Monday after reporting a mixed second-quarter picture. Allergan posted a loss of $501.7 million for the quarter. Earnings of $3.35 a share surpassed Wall Street’s expectations by 7 cents. But, revenue of nearly $3.7 billion dollars for the period fell far short of analysts’ predictions. For the full year, Allergan sees earnings of between $13.75 and $14.20 a share. Analysts had been looking for earnings of $14.21 a share. Allergan now expects revenue of $14.65 billion to $14.90 billion, which is more than a billion dollars below forecasts.
Subscribe to TheStreetTV on YouTube:
For more content from TheStreet visit:
Check out all our videos:
Follow TheStreet on Twitter:
Like TheStreet on Facebook:
Follow TheStreet on LinkedIn:
Follow TheStreet on Google+:
source
